Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exforge switch study in uncontrolled essential hypertension after olmesartan + amlodipine
2007-001374-87Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of amlodipine + valsartan in essential hypertension, sponsored by Novartis. Started May 2007; status: completed.
02
Drugs
amlodipine + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-001374-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001374-87.